Clinical journal of gastroenterology · 2025
EUS-guided ethanol ablation in patients with solid pseudopapillary neoplasm: a four-case series.
СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Myung Yousik, Hara Kazuo, Haba Shin, Kuwahara Takamichi, Okuno Nozomi, Koda Hiroki, Melianti Indria, Agyei-Nkansah Adwoa
Аннотация
BACKGROUND/AIMS: Solid pseudopapillary neoplasm (SPN) of the pancreas is a rare tumor with low malignant potential, though 10-15% may show invasive or metastatic behavior. This study aimed to evaluate the safety and efficacy of endoscopic ultrasound-guided ethanol ablation (EUS-EI) in patients with SPN who were not surgical candidates.
METHODS: Four patients with SPN who declined or were ineligible for surgery underwent EUS-EI at Aichi Cancer Center. Technical and clinical outcomes, as well as adverse events, were assessed.
RESULTS: Technical success was achieved in all patients (100%). Clinical success was observed in three patients (75%), including two with complete ablation and one with significant tumor reduction. No major adverse events or tumor recurrence occurred during follow-up.
CONCLUSIONS: EUS-EI may be a safe and effective alternative for managing SPN in non-surgical candidates.
METHODS: Four patients with SPN who declined or were ineligible for surgery underwent EUS-EI at Aichi Cancer Center. Technical and clinical outcomes, as well as adverse events, were assessed.
RESULTS: Technical success was achieved in all patients (100%). Clinical success was observed in three patients (75%), including two with complete ablation and one with significant tumor reduction. No major adverse events or tumor recurrence occurred during follow-up.
CONCLUSIONS: EUS-EI may be a safe and effective alternative for managing SPN in non-surgical candidates.